Authors:
Rosenthal, MA
Kavar, B
Hill, JS
Morgan, DJ
Nation, RL
Stylli, SS
Basser, RL
Uren, S
Geldard, H
Green, MD
Kahl, SB
Kaye, AH
Citation: Ma. Rosenthal et al., Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin, J CL ONCOL, 19(2), 2001, pp. 519-524
Citation: Bl. Coffman et al., Analysis of opioid binding to UDP-glucuronosyltransferase 2B7 fusion proteins using nuclear magnetic resonance spectroscopy, MOLEC PHARM, 59(6), 2001, pp. 1464-1469
Authors:
Davis, ID
Maher, DW
Cebon, JS
Green, MD
Fox, RM
McKendrick, JJ
Rybak, ME
Boyd, AW
Citation: Id. Davis et al., A phase I and pharmacokinetic study of subcutaneously-administered recombinant human interleukin-4 (rhuIL-4) in patients with advanced cancer, GROW FACTOR, 17(4), 2000, pp. 287
Authors:
Basser, RL
Underhill, C
Davis, I
Green, MD
Cebon, J
Zalcberg, J
MacMillan, J
Cohen, B
Marty, J
Fox, RM
Begley, CG
Citation: Rl. Basser et al., Enhancement of platelet recovery after myelosuppressive chemotherapy by recombinant human megakaryocyte growth and development factor in patients with advanced cancer, J CL ONCOL, 18(15), 2000, pp. 2852-2861
Citation: Md. Green et al., A colorimetric field method to assess the authenticity of drugs sold as the antimalarial artesunate, J PHARM B, 24(1), 2000, pp. 65-70
Citation: Md. Green et Ja. Rice, Channel-tolerant FH-MFSK acoustic signaling for undersea communications and networks, IEEE J OCEA, 25(1), 2000, pp. 28-39
Authors:
Breyer-Pfaff, U
Mey, U
Green, MD
Tephly, TR
Citation: U. Breyer-pfaff et al., Comparative N-glucuronidation kinetics of ketotifen and amitriptyline by expressed human UDP-glucuronosyltransferases and liver microsomes, DRUG META D, 28(8), 2000, pp. 869-872
Authors:
Barbier, O
Turgeon, D
Girard, C
Green, MD
Tephly, TR
Hum, DW
Belanger, A
Citation: O. Barbier et al., 3 '-azido-3 '-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7), DRUG META D, 28(5), 2000, pp. 497-502
Citation: Md. Green, A new order of things: Property, power, and the transformation of the Creek Indians, 1733-1816., AM HIST REV, 105(5), 2000, pp. 1733-1733
Authors:
Green, MD
Bergqvist, Y
Mount, DL
Corbett, S
D'Souza, MJ
Citation: Md. Green et al., Improved validated assay for the determination of mefloquine and its carboxy metabolite in plasma, serum and whole blood using solid-phase extractionand high-performance liquid chromatography, J CHROMAT B, 727(1-2), 1999, pp. 159-165
Authors:
Gall, WE
Zawada, G
Mojarrabi, B
Tephly, TR
Green, MD
Coffman, BL
Mackenzie, PI
Radominska-Pandya, A
Citation: We. Gall et al., Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7, J STEROID B, 70(1-3), 1999, pp. 101-108
Authors:
Talbot, SM
Westerman, DA
Grigg, AP
Toner, GC
Wolf, M
Bishop, J
McKendrick, J
Zalcberg, J
Levi, J
Fox, RM
Green, MD
Citation: Sm. Talbot et al., Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors, ANN ONCOL, 10(8), 1999, pp. 907-914
Authors:
Basser, RL
Abraham, R
To, LB
Fox, RM
Green, MD
Citation: Rl. Basser et al., Cardiac effects of high-dose epirubicin and cyclophosphamide in women withpoor prognosis breast cancer, ANN ONCOL, 10(1), 1999, pp. 53-58
Authors:
Clarke, K
Basser, RL
Underhill, C
Mitchell, P
Bartlett, J
Cher, L
Findlay, M
Dalley, D
Pell, M
Byrne, M
Geldard, H
Hill, JS
Maher, D
Fox, RM
Green, MD
Kaye, AH
Citation: K. Clarke et al., KRN8602 (MX2-hydrochloride): An active new agent for the treatment of recurrent high-grade glioma, J CL ONCOL, 17(8), 1999, pp. 2579-2584
Authors:
Basser, RL
To, LB
Collins, JP
Begley, CG
Keefe, D
Cebon, J
Bashford, J
Durrant, S
Szer, J
Kotasek, D
Juttner, CA
Russell, I
Maher, DW
Olver, I
Sheridan, WP
Fox, RM
Green, MD
Citation: Rl. Basser et al., Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: Five-year follow-up, J CL ONCOL, 17(1), 1999, pp. 82-92
Citation: Bs. Ooi et al., Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer - An overview, DIS COL REC, 42(3), 1999, pp. 403-418